Phase I clinical and pharmacologic study of docetaxel and gemcitabine in patients with advanced solid tumors; a novel two week schedule

被引:0
|
作者
Obrocea, M
Davis, TH
Lewis, LD
Maurer, LH
Pipas, JM
Smith, EL
Meyer, LP
Hammond, S
Rigas, JR
机构
[1] Dartmouth Coll, Hitchcock Med Ctr, Lebanon, NH 03756 USA
[2] Norris Cotton Canc Ctr, Lebanon, NH 03756 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
363
引用
收藏
页码:95 / 95
页数:1
相关论文
共 50 条
  • [1] Phase I study on docetaxel and Gemcitabine in patients with advanced solid tumors
    Jaremtchuk, AV
    Zarba, JJ
    Ferro, A
    ANNALS OF ONCOLOGY, 1998, 9 : 138 - 139
  • [2] Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumors
    Pronk, LC
    Schellens, JHM
    Planting, AST
    vandenBent, MJ
    Hilkens, PHE
    vanderBurg, MEL
    deBoerDennert, M
    Ma, J
    Blanc, C
    Harteveld, M
    Bruno, R
    Stoter, G
    Verweij, J
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) : 1071 - 1079
  • [3] A phase I study of gemcitabine and docetaxel for advanced stage solid tumors
    Poole, ME
    Bernard, SA
    Churchel, MA
    Weissler, MC
    Calvo, B
    Cance, W
    Ollila, D
    Koruda, M
    Behrns, K
    Detterbeck, FC
    CANCER INVESTIGATION, 2003, 21 (03) : 350 - 354
  • [4] A phase I study of gemcitabine and docetaxel in patients with metastatic solid tumors
    Ryan, DP
    Lynch, TJ
    Grossbard, ML
    Seiden, MV
    Fuchs, CS
    Grenon, N
    Baccala, P
    Berg, D
    Finkelstein, D
    Mayer, RJ
    Clark, JW
    CANCER, 2000, 88 (01) : 180 - 185
  • [5] Phase I and pharmacologic study of sequences of gemcitabine and the multitargeted antifolate agent in patients with advanced solid tumors
    Adjei, AA
    Erlichman, C
    Sloan, JA
    Reid, JM
    Pitot, HC
    Goldberg, RM
    Peethambaram, P
    Atherton, P
    Hanson, LJ
    Alberts, SR
    Jett, J
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (08) : 1748 - 1757
  • [6] Gemcitabine and Docetaxel in patients with advanced solid tumors. A GETICS phase I trial
    Jaremtchuk, AV
    Zabra, JJ
    Ferro, A
    Aman, EF
    Alvarez, R
    Arroyo, G
    Marmissolle, F
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S290 - S290
  • [7] Phase I study of docetaxel and ifosfamide in patients with advanced solid tumors
    Pronk, L
    Shrijvers, D
    LocciTonelli, D
    Verweij, J
    VanOosterom, AT
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 961 - 961
  • [8] Phase I study of piritrexim and gemcitabine in patients with advanced solid tumors
    Huie, M
    Carducci, M
    Liu, G
    Wilding, GG
    Marnocha, R
    Izquierda, M
    Thomas, J
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (06): : 613 - 617
  • [9] A phase I clinical study of biweekly pemetrexed and gemcitabine in patients with advanced solid tumors.
    Dudek, A
    Larson, T
    Mellskog, CE
    Bloss, LP
    Obasaju, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 162S - 162S
  • [10] Phase I study of 3-week schedule of irinotecan combined with cisplatin in patients with advanced solid tumors
    de Jonge, MJA
    Sparreboom, A
    Planting, AST
    van der Burg, MEL
    de Boer-Dennert, MM
    ter Steeg, J
    Jacques, C
    Verweij, J
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (01) : 187 - 194